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HEALTH TECHNOLOGY ASSESSMENT IN DEVELOPING COUNTRIES: 
WHAT IS THE STATE OF PLAY?
Shankland B, Mendes da Costa S
Double Helix Consulting, London, UK
OBJECTIVES: Health Technology (HTA) groups play an important role in health care
decision-making in the developed world. Previous studies have suggested that their 
impact is dependent on certain internal and external markers of capability. It is unclear 
if these markers are applicable to so-called ‘developing countries’. METHODS: A total 
of 122 respondents in 20 middle-income countries were interviewed over a 9-month 
period in 2008. The sample comprised health economists (27%), medical practitioners
(19%); health care decision makers with knowledge of pharmacoeconomics (26%),
and technology suppliers (28%). Health economists were surveyed about their group’s
preferred methodology of analysis, sources, therapeutic areas of interest and end cus-
tomers. Clinical and ﬁ nancial decision- makers were surveyed about their use of 
pharmacoeconomics in treatment and coverage decisions; relationships with stake-
holders; and other decision criteria. Technology suppliers were surveyed about formal 
and informal interactions with decision makers and their pharmacoeconomic require-
ments. A metric with three weighted variables was created. The variable measured
the technical sophistication of HTA groups according to a series of methodological 
markers; the second variable measured decision making transparency according to a
series of process markers; additionally, a third variable measured external environ-
mental factors impacting technology adoption. An adapted Boston Matrix was created
from these three variables. HTA groups in the Matrix were classiﬁ ed as ‘advanced’;
‘intermediate’; and ‘nascent’. RESULTS: Only 9% of the HTA groups surveyed quali-
ﬁ ed as ‘advanced’, and 23% of HTA groups qualiﬁ ed as ‘nascent’. A majority (68%) 
qualiﬁ ed as ‘intermediate’, suggesting a relationship to decision making despite great
diversity in their technical capabilities. Correlations between environmental factors 
and technical sophistication, but not process transparency, were observed. CONCLU-
SIONS: The technical sophistication of HTA groups varies widely in developing 
countries and is independent of conventional process and environmental markers.
Further research is needed to establish the additional drivers of HTA development in 
each country.
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RED BLOOD CELL TRANSFUSION PRACTICES IN VA INTENSIVE
CARE UNITS: HOW DO THEY VARY FOR PATIENTS WITH HEART AND
CHRONIC KIDNEY DISEASE?
Ding YY1, Berlowitz DR2, Kader B2, Christiansen CL2
1Tan Tock Seng Hospital, and National Healthcare Group Health Services & Outcomes
Research, Singapore, Singapore, 2Center for Health Quality, Outcomes & Economic Research, 
Bedford VA Hospital, Bedford, MA, Bedford, MA, USA
OBJECTIVES: Red blood cell (RBC) transfusions are commonly administered in the
care of critically ill patients. However, it is less clear how transfusion practice varies 
with hemoglobin (Hgb) level and with presence of heart and chronic kidney disease. 
We sought to describe the frequency of RBC transfusions among critically ill patients, 
how it varies with Hgb level, and to identify other associated patient characteristics. 
METHODS: This was a retrospective observational study involving secondary analy-
sis of administrative data of patients admitted to Veterans Affairs (VA) intensive care 
units (ICU) from 2001 to 2005. First ICU admissions of the year for unique patients 
were included. The outcome of interest was RBC transfusion during the ﬁ rst 30 days
of ICU admission. Explanatory variables include demographic and admission-related
information, Hgb level, co-morbid conditions, ICU admission diagnosis, and labora-
tory test results. Logistic regression modeling quantiﬁ ed associations between these 
variables and transfusion. RESULTS: The data of 259,281 admissions were analyzed.
Overall incidence of RBC transfusion was 12.5%, varying from 0.6% for Hgb above 
12 g/dl, to 68.0% for Hgb below 5 g/dl. Increased age (OR 1.05, 95%CI 1.03–1.06 
every 10 years), male gender (OR 1.19, 95%CI 1.08–1.30), admission for acute
myocardial infarction (AMI) (OR 1.28, 95%CI 1.21–1.36), and co-morbid heart 
disease (OR 1.05, 95%CI 1.02–1.09) were independently associated with transfusion,
but chronic kidney disease was not. Signiﬁ cant interactions between Hgb level and 3 
admission diagnoses (AMI, angina, and congestive heart failure) resulted in even
higher likelihood of transfusion among patients admitted for these conditions and had 
lower Hgb levels. CONCLUSIONS: Independent of Hgb level, ICU patients admitted 
for AMI, angina or congestive heart failure had higher likelihood of RBC transfusion,
with this likelihood increasing even further among those with lower Hgb levels.
Further research is needed to determine how these practices inﬂ uence outcomes.
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PHYSICIAN KNOWLEDGE AND CONFIDENCE IN APPROPRIATE
MEDICATION PRESCRIBING IN THE ELDERLY: A SURVEY STUDY IN
PARMA, ITALY
Maio V1, Abouzaid S1, Negri G2, Donatini A3
1Thomas Jefferson University, Philadelphia, PA, USA, 2LHU Parma, Parma, Parma, Italy, 3LHU 
Parma, Parma, Italy
OBJECTIVES: To assess general practitioners’ (GPs) conﬁ dence in and knowledge of 
appropriate medication prescribing in elderly patients. METHODS: A total of 155 GPs 
(51% of the total number of GPs convened by the Local Health Unit (LHU) of 
Parma for an educational session), were asked to complete anonymously a 21-item
paper survey. Physician demographics were collected. Conﬁ dence in prescribing for
the elderly was measured using a 5-point Likert scale. Knowledge of inappropriate
medication use in the elderly was assessed using 7 clinical vignettes based on the 2003 
Beers Criteria, and a score out of 7 was assigned depending on the number of correct
responses. Topics tested included hypertension, osteoarthritis, arrhythmias, insomnia, 
and depression. Data regarding physician’s perceived barriers to appropriate prescrib-
ing for elderly patients was collected. Descriptive analyses using Fisher’s exact test
and t-test were conducted as appropriate. RESULTS: All GPs completed the survey. 
Respondents were 76% male, had a mean age of 54 (SD o 5.0), and mean years in
practice of 22 (SD o 8.3). Most physicians (88%) felt conﬁ dent in their ability to pre-
scribe appropriate medications for the elderly. Sixty-nine percent of physicians had 
never heard of the Beers Criteria for potentially inappropriate prescribing in the
elderly. The mean score in the clinical vignettes was 4.6 (SD o 1.3). Comparison of 
characteristics of lower score (a3) respondents versus higher score (q6) respondents 
revealed that the former have been in practice for a longer time (p  0.005). Perceived 
barriers to appropriate prescribing included potential drug interactions (79% of 
respondents) and the large number of medications a patient is already taking (75%). 
CONCLUSIONS: While the majority of GPs feel conﬁ dent in their prescribing for 
elderly patients, there is room for improvement regarding their knowledge of appropri-
ate prescribing. Educational strategies tailored to speciﬁ c GPs’ categories should be
establish to enhance knowledge in this area and improve quality of prescribing.
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25 YEARS OF ECONOMIC EVALUATION IN MEXICO: A SYSTEMATIC
REVIEW OF ARTICLES PUBLISHED IN THE ECONOMIC AND MEDICAL
LITERATURE: 1984–2009
Mould-Quevedo J1, Contreras-Hernandez I2
1Pﬁ zer Mexico, Mexico City, Mexico, 2Social Security Mexican Institute, Mexico City, Mexico
OBJECTIVES: To assess the state of the art of economic evaluations (EE) of health 
care programs researches in Mexico, regarding their methodological quality and 
current tendencies. METHODS: Systematic review of Mexican studies on EE in health, 
published in national and international journals from January 1984(ﬁ rst Mexican 
article published) to January 2009. We searched multiple electronic databases 
(PubMed, Embase, Mediagraphic, Imbiomed, Latinmed), hand-searched key journals 
and personally contacted investigators in January 2009. Two health economist review-
ers independently assessed the relevance of retrieved articles, described the methods 
of included studies and extracted data that was summarized by consensus. Drum-
mond’s criteria were used: a) to classify between complete economic evaluation (CEE)
or partial economic evaluation (PEE), and b) to assess the criteria quality of methodol-
ogy. Publication characteristics analyses were conducted with descriptive and analytic
statistics. Limitation: only published studies in journals were included(abstracts, book
chapters or technical reports were excluded). RESULTS: A total of 101 studies
matched inclusion criteria: 48.5% were CEE and 51.5% were PEE. Number of 
CEEs in Mexico increased signiﬁ cantly among 2005–2009(14 studies), showing a
71.8% increase in all EE. A total of 73.3% of manuscripts were published in Mexican 
Journals and 81.6% corresponded to cost-effectiveness analyses. Articles covered 
emphasis on nephrology (9.0%) and infectology (8.4%). Regarding 2008–2009 
methodology quality improvement in comparison to 2004 publications: 40.8% 
didn’t mention study perspective (vs.66.7% in 2004, p  0.05), 44.9% didn’t report 
sensitivity analyses (vs.66.7% in 2004, p  0.05), 30.0% didn’t report discount rate
when it was necessary(vs.63.5% in 2004, p  0.05) and only 40.8% studies estimated 
an ICER (vs.37.5% in 2004, p  0.12). During 1984–2009, only 28.6% of published
studies reported probabilistic sensitivity analyses and 18.4% used a decision tree-
model in the assessment(main economic model used). CONCLUSIONS: An increase 
in CEEs in Mexico with a small improvement on quality methodology during the last
ﬁ ve-year period.
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MEXICAN POSTER PRESENTATIONS AT ISPOR MEETINGS: 
A QUALITY AND TENDENCY ASSESSMENT 2003–2008
Mould-Quevedo J1, Contreras-Hernandez I2
1Pﬁ zer Mexico, Mexico City, Mexico, 2Social Security Mexican Institute, Mexico City, Mexico
OBJECTIVES: To assess the state of the art of Mexican pharmacoeconomics (PE) and 
outcomes research (OR) poster presentations at International Society for Pharmaco-
economics and Outcomes Research(ISPOR) meetings, regarding methodological 
quality and current tendencies. METHODS: Systematic review of Mexican presenta-
tions on PE and OR at ISPOR Meetings from May 2003 (ﬁ rst Mexican poster pre-
sentation) to November 2008. We searched abstracts and poster presentations at
Annual International Meetings, Annual European Congresses and Latin America
Conferences. Two health economist reviewers assessed the relevance of retrieved 
abstracts, described the methods of included studies and extracted data that was sum-
marized by consensus. Drummond’s criteria were used: a) to classify between complete 
economic evaluation (CEE) or partial economic evaluation; and b) to assess the criteria 
quality of methodology. Abstracts characteristics analyses were conducted with 
descriptive and analytic statistics. RESULTS: A total of 116 abstracts matched inclu-
sion criteria: 97 were PE (83.6%), 13 were OR (11.2%) and 6 were clinical trials 
results (5.2%). A total of 82.5% of PE abstracts were CEE. During the past two years
presentations increased signiﬁ cantly(16 studies), showing an 88.9% growth. A total
of 60.3% of studies were performed at the Social Security Mexican Institute(IMSS) 
and 70.1% of PE presentations corresponded to cost-effectiveness analyses. Posters 
covered a wide range of conditions, with emphasis on cardiovascular diseases (19.8%) 
and oncology (12.1%). Regarding quality of CEE studies: 27.4% didn’t mention study 
perspective, 40.3% didn’t report analyses, 39.1% didn’t report discount rate when it 
was necessary(time horizon above 1-year) and only 52.6% studies estimated an ICER.
A total of 69.0% of these studies had a pharmaceutical-industry sponsor, 34.5% were
